Concepedia

Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels

Yuki Horiuchi, Satoshi Hirayama, Satoshi Soda, Utako Seino, Mika Kon, Tsuyoshi Ueno, Mayumi Idei, Osamu Hanyu, Takashi Tsuda, Hirotoshi Ohmura,

Journal of Atherosclerosis and Thrombosis · 2010 · 41 citations · 18 references

DOIFull text

Open access

Abstract

Statin therapy reduces inflammatory markers in hypercholesterolemic patients, and this anti-inflammatory action is limited to patients whose inflammatory markers are elevated at baseline.

References

18

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

, , +8

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé et al. · New England Journal of Medicine · 1996 · 7.5K citations · Full text

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca et al. · New England Journal of Medicine · 2008 · 6.5K citations · Full text

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Paul M. Ridker, Nader Rifai, Lynda Rose et al. · New England Journal of Medicine · 2002 · 3.6K citations · Full text